Immunocore Holdings plc American Depositary Shares
Symbol: IMCR (NASDAQ)
Company Description:
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
- Today's Open: $36.52
- Today's High: $36.645
- Today's Low: $35.217
- Today's Volume: 184.76K
- Yesterday Close: $36.57
- Yesterday High: $36.65
- Yesterday Low: $35.91
- Yesterday Volume: 162.24K
- Last Min Volume: 1
- Last Min High: $35.245
- Last Min Low: $35.245
- Last Min VWAP: $35.245
- Name: Immunocore Holdings plc American Depositary Shares
- Website: https://www.immunocore.com
- Listed Date: 2021-02-05
- Location: OXFORDSHIRE, X0
- Market Status: Active
- CIK Number: 0001671927
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.78B
- Round Lot: 100
- Outstanding Shares: 50.39M
- Asset Type: ADRC
Filing Date | Filing Type | Format |
---|---|---|
2025-09-12 | 4 | View |
2025-09-10 | 144 | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-07 | 8-K | View |
2025-08-07 | 10-Q | View |
2025-08-05 | SCHEDULE 13G/A | View |
2025-08-05 | SCHEDULE 13G/A | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-19 | 4 | View |
2025-05-15 | 8-K | View |
2025-05-14 | SCHEDULE 13G/A | View |
2025-05-12 | SCHEDULE 13G/A | View |
2025-05-07 | S-8 | View |
2025-05-07 | 8-K | View |
2025-05-07 | 10-Q | View |